Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Receivables - Net: 2024

Historic Receivables - Net for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Dec 2024 value amounting to $7.6 million.

  • Syndax Pharmaceuticals' Receivables - Net was N/A to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2024, which is N/A change from last year.
  • As of FY2024, Syndax Pharmaceuticals' Receivables - Net stood at $7.6 million.
  • Syndax Pharmaceuticals' 5-year Receivables - Net high stood at $7.6 million for FY2024, and its period low was $7.6 million during FY2024.
  • For the 1-year period, Syndax Pharmaceuticals' Receivables - Net averaged around $7.6 million, with its median value being $7.6 million (2024).